These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 14631560)

  • 61. Non-Goodpasture anti-GBM antibodies in patients with glomerulonephritis.
    Bygren P; Cederholm B; Heinegård D; Wieslander J
    Nephrol Dial Transplant; 1989; 4(4):254-61. PubMed ID: 2502732
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Immunological properties of the human Goodpasture target antigen.
    Weber M; Meyer zum Büschenfelde KH; Köhler H
    Clin Exp Immunol; 1988 Nov; 74(2):289-94. PubMed ID: 3224445
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The importance of cell-mediated immunity in the course and severity of autoimmune anti-glomerular basement membrane disease in mice.
    Hopfer H; Maron R; Butzmann U; Helmchen U; Weiner HL; Kalluri R
    FASEB J; 2003 May; 17(8):860-8. PubMed ID: 12724345
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Circulating anti-glomerular basement membrane autoantibodies against α3(IV)NC1 undetectable by commercially available enzyme-linked immunosorbent assays.
    Jia XY; Qu Z; Cui Z; Yang R; Zhao J; Zhao MH
    Nephrology (Carlton); 2012 Feb; 17(2):160-6. PubMed ID: 21854504
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A rapid assay for circulating anti-glomerular basement membrane antibodies in Goodpasture syndrome.
    Saxena R; Isaksson B; Bygren P; Wieslander J
    J Immunol Methods; 1989 Mar; 118(1):73-8. PubMed ID: 2647855
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Reactive oxygen species expose cryptic epitopes associated with autoimmune goodpasture syndrome.
    Kalluri R; Cantley LG; Kerjaschki D; Neilson EG
    J Biol Chem; 2000 Jun; 275(26):20027-32. PubMed ID: 10748075
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Properties of bovine nephritogenic antigen that induces anti-GBM nephritis in rats and its similarity to the Goodpasture antigen.
    Sado Y; Kagawa M; Naito I; Okigaki T
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1991; 60(5):345-51. PubMed ID: 1722595
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Advances in the pathogenesis of Goodpasture's disease: from epitopes to autoantibodies to effector T cells.
    Ooi JD; Holdsworth SR; Kitching AR
    J Autoimmun; 2008 Nov; 31(3):295-300. PubMed ID: 18502098
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Goodpasture syndrome: selective removal of anti-alpha 3 (IV) collagen autoantibodies. A potential therapeutic alternative to plasmapheresis.
    Boutaud AA; Kalluri R; Kahsai TZ; Noelken ME; Hudson BG
    Exp Nephrol; 1996; 4(4):205-12. PubMed ID: 8864724
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Induction of anti-GBM nephritis in rats by recombinant alpha 3(IV)NC1 and alpha 4(IV)NC1 of type IV collagen.
    Sado Y; Boutaud A; Kagawa M; Naito I; Ninomiya Y; Hudson BG
    Kidney Int; 1998 Mar; 53(3):664-71. PubMed ID: 9507212
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A Modified Peptide Derived from Goodpasture Autoantigen Arrested and Attenuated Kidney Injuries in a Rat Model of Anti-GBM Glomerulonephritis.
    Shi Y; Jia XY; Gu QH; Wang M; Cui Z; Zhao MH
    J Am Soc Nephrol; 2020 Jan; 31(1):40-53. PubMed ID: 31666297
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Anti-glomerular basement membrane nephritis and bullous pemphigoid caused by distinct anti-alpha 3(IV)NC1 and anti-BP180 antibodies in a patient with Crohn's disease.
    Plaisier E; Borradori L; Hellmark T; Wattiaux MJ; Flageul B; Mougenot B; Ronco P
    Am J Kidney Dis; 2002 Sep; 40(3):649-54. PubMed ID: 12200819
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Experimental Goodpasture's syndrome in Wistar-Kyoto rats immunized with alpha3 chain of type IV collagen.
    Abbate M; Kalluri R; Corna D; Yamaguchi N; McCluskey RT; Hudson BG; Andres G; Zoja C; Remuzzi G
    Kidney Int; 1998 Nov; 54(5):1550-61. PubMed ID: 9844131
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Central tolerance regulates B cells reactive with Goodpasture antigen alpha3(IV)NC1 collagen.
    Zhang Y; Su SC; Hecox DB; Brady GF; Mackin KM; Clark AG; Foster MH
    J Immunol; 2008 Nov; 181(9):6092-100. PubMed ID: 18941198
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Identification of Goodpasture antigens in human alveolar basement membrane.
    Yoshioka K; Iseki T; Okada M; Morimoto Y; Eryu N; Maki S
    Clin Exp Immunol; 1988 Dec; 74(3):419-24. PubMed ID: 2466590
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Molecular mapping of the Goodpasture's epitope for glomerulonephritis.
    Bolton WK; Chen L; Hellmark T; Fox J; Wieslander J
    Trans Am Clin Climatol Assoc; 2005; 116():229-36; discussion 237-8. PubMed ID: 16555617
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Goodpasture syndrome.
    Kalluri R
    Kidney Int; 1999 Mar; 55(3):1120-2. PubMed ID: 10027952
    [No Abstract]   [Full Text] [Related]  

  • 78. Rapidly progressive glomerulonephritis due to anti-glomerular basement membrane disease accompanied by IgA nephropathy: An unusual association.
    Annamalai I; Chandramohan G; Srinivasa Prasad ND; Fernando E; Sujith S
    Saudi J Kidney Dis Transpl; 2017; 28(6):1404-1407. PubMed ID: 29265054
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Modeling of human anti-GBM antibody-alpha3(IV)NC1 interactions predicts antigenic cross-linking through contact of both heavy chains with repeating epitopes on alpha3(IV)NC1.
    Meyers KE; Christensen M; Madaio MP
    Am J Nephrol; 2009; 30(5):474-80. PubMed ID: 19786737
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Failure of plasma exchange and immunosuppression to improve renal function in Goodpasture's syndrome.
    McLeish KR; Maxwell DR; Luft FC
    Clin Nephrol; 1978 Aug; 10(2):71-3. PubMed ID: 699402
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.